Tristel plc (LON:TSTL – Get Free Report) hit a new 52-week low on Thursday . The company traded as low as GBX 331 ($4.33) and last traded at GBX 433.40 ($5.67), with a volume of 114851 shares. The stock had previously closed at GBX 432.50 ($5.66).
Tristel Price Performance
The stock has a market cap of £204.77 million, a PE ratio of 3,583.33 and a beta of 0.23. The company has a debt-to-equity ratio of 19.12, a quick ratio of 3.83 and a current ratio of 4.92. The business has a 50 day moving average price of GBX 467.86 and a two-hundred day moving average price of GBX 457.87.
Tristel Company Profile
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.
Further Reading
- Five stocks we like better than Tristel
- What Are Dividend Achievers? An Introduction
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- Conference Calls and Individual Investors
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- How is Compound Interest Calculated?
- MarketBeat Week in Review – 9/9 – 9/13
Receive News & Ratings for Tristel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tristel and related companies with MarketBeat.com's FREE daily email newsletter.
